Psilocybin Exposures Reported to U.S. Poison Centers: National Trends Over a Decade.

Publisher: Elsevier Country of Publication: United States NLM ID: 9102136 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1972 (Electronic) Linking ISSN: 1054139X NLM ISO Abbreviation: J Adolesc Health Subsets: MEDLINE

Original Publication: New York, NY : Elsevier, c1991-

Psilocybin* ; Poisons*; Adolescent ; Young Adult ; Humans ; United States/epidemiology ; Poison Control Centers ; Databases, Factual

Purpose: We describe trends in psilocybin exposures among adolescents and young adults as reported to US poison centers over the past decade.
Methods: We queried the National Poison Data System for cases involving psilocybin during January 1, 2013-December 31, 2022. Persons aged 13-25 years were included. We examined exposures to psilocybin by demographics, clinical effects, level of care, and medical outcome.
Results: During the 10-year study period, 4,055 psilocybin-involved exposures were reported among adolescents and young adults, 2,667 (65.8%) being single substance exposures. Most single substance cases received medical attention (adolescents: 75.3% [n = 1,176], young adults: 72.1% [n = 797]). We did not find significant change in the number of cases during 2013-2018. Cases started increasing in 2019. In 2022, cases more than tripled among adolescents and more than doubled among young adults, compared to 2018 (p < .0001).
Discussion: Continued national surveillance is critical to determine the impact of psilocybin exposures on youth as it becomes increasingly available.
(Copyright © 2024 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.)

Keywords: Adolescents; NPDS; Psilocybin; Surveillance; Young adults

2RV7212BP0 (Psilocybin)
0 (Poisons)

Date Created: 20240228 Date Completed: 20240422 Latest Revision: 20240422

20240422

10.1016/j.jadohealth.2024.01.027

38416101